forresearchers
thenetherlandscountry
Go back to Database: Registry of Histo and Cytopathology (The Netherlands) page.
Source: Click here to learn more
The variables are different according to the type of tumour that is registered. Here is an overview of the available variables. The lists for each type of tumour are available for download in the section "National histology protocols" in the source website link.
| PALGApatiëntnr |
Ascending patient number that is recreated for each request. The concept of 'patient' is based on equality of name (first 4 letters), date of birth, and gender.
|
| PALGAexcerptnr |
Chronological numbering of excerpts within a patient.
|
| Selectie |
Method of selecting the excerpts (most common example: 1 = target selection excerpt, 3 = history excerpt).
|
| Kans_admin_meerling |
The likelihood that excerpts assigned the same PALGA patient number are not from the same patient (ranging from none to present-real, and depending on the amount of available information per excerpt).
|
| Datum ontvangst |
Date of receipt of PA material at the PA department.
|
| Soort onderzoek |
Type of examination (T=histology, C=cytology, B=population cytology, S=autopsy).
|
| Geslacht |
Gender of patient.
|
| Leeftijd |
Age of patient at the time of receipt of PA material at the PA department.
|
| Jaar onderzoek |
Year of receipt of PA material at the PA department.
|
| Conclusie |
Conclusion from the pathology report.
|
| PALGA-diagnoses |
Diagnostic rules associated with the pathology report.
|
| PALGA-codes |
Coded diagnostic rules associated with the pathology report.
|
|
Macroscopy
|
|
Microscopy
|
|
Epicrise
|
|
(Anonymous) lab number - provided that this does not make laboratories traceable or with the permission of the individual laboratories.
|
|
Academic or non-academic laboratory
|
|
Date of last authorization of the report
|
|
Research done in the context of population research into colon cancer
|
|
KOPACB in cervical cytology
|
| Clinical data and Macroscopy
|
| Type of resection
|
| Versatility
|
| Tumour localization
|
| Tumour diameter
|
| Supplied lymph node stations
|
| Clinical metastases
|
| Previous therapies
|
| Previous operations
|
| Type of excision
|
| Microscopy
|
| Metastasis occurrence and location
|
| Previously diagnosed tumours by type
|
| Localization of primary tumour
|
| Type of tumour (WHO)
|
| Tumour diameter
|
| Diameter of invasive component
|
| Degree of Differentiation
|
| Histological patterns
|
| Mitoses per 2mm2
|
| Necrosis
|
| Tumour morphology
|
| Type of Pre-invasive lesion (WHO)
|
| Response to neoadjuvant therapy
|
| Percentage of tumour residual
|
| Percentage of necrosis
|
| Percentage of stroma
|
| Lymph node involvement
|
| Immunohistochemistry
|
| Immunopositivity of substances related to cancer (PDL1, KI67...)
|
| Immunonegativity of substances related to cancer (PDL1, KI67...)
|
| Percentage of positive tumour cell nuclei
|
| Molecular
|
| Types of mutations on genes
|
